These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12094337)

  • 1. Pemetrexed: translational research in breast cancer.
    Hanauske AR
    Semin Oncol; 2002 Jun; 29(3 Suppl 9):40-2. PubMed ID: 12094337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pemetrexed (Alimta): a promising new agent for the treatment of breast cancer.
    Calvert H
    Semin Oncol; 2003 Apr; 30(2 Suppl 3):2-5. PubMed ID: 12722017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translational research with pemetrexed in breast cancer.
    Hanauske AR
    Oncology (Williston Park); 2004 Nov; 18(13 Suppl 8):66-9. PubMed ID: 15655941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pemetrexed: a promising new treatment for breast cancer.
    O'Shaughnessy JA; Gennari A; Conte P
    Semin Oncol; 2002 Apr; 29(2 Suppl 5):36-41. PubMed ID: 12023791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incorporation of pemetrexed (Alimta) into the treatment of non-small cell lung cancer (thoracic tumors).
    Bunn PA
    Semin Oncol; 2002 Jun; 29(3 Suppl 9):17-22. PubMed ID: 12094334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pemetrexed: an active new agent for breast cancer.
    O'Shaughnessy JA
    Semin Oncol; 2002 Dec; 29(6 Suppl 18):57-62. PubMed ID: 12571813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase II trial of pemetrexed in advanced breast cancer: clinical response and association with molecular target expression.
    Gomez HL; Santillana SL; Vallejos CS; Velarde R; Sanchez J; Wang X; Bauer NL; Hockett RD; Chen VJ; Niyikiza C; Hanauske AR
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):832-8. PubMed ID: 16467096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gemcitabine and Pemetrexed disodium in treating breast cancer.
    Adjei AA
    Oncology (Williston Park); 2001 Feb; 15(2 Suppl 3):34-7. PubMed ID: 11252887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pemetrexed in the treatment of selected solid tumors.
    Adjei AA
    Semin Oncol; 2002 Apr; 29(2 Suppl 5):50-3. PubMed ID: 12023793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pemetrexed in pancreatic cancer.
    Kindler HL
    Semin Oncol; 2002 Dec; 29(6 Suppl 18):49-53. PubMed ID: 12571811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of a promising new agent--pemetrexed disodium.
    Paz-Ares L; Bezares S; Tabernero JM; Castellanos D; Cortes-Funes H
    Cancer; 2003 Apr; 97(8 Suppl):2056-63. PubMed ID: 12673697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pemetrexed (Alimta): improving outcomes in malignant pleural mesothelioma.
    Budde LS; Hanna NH
    Expert Rev Anticancer Ther; 2004 Jun; 4(3):361-8. PubMed ID: 15161435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced folate carrier and folylpolyglutamate synthetase, but not thymidylate synthase predict survival in pemetrexed-treated patients suffering from malignant pleural mesothelioma.
    Mairinger F; Vollbrecht C; Halbwedl I; Hatz M; Stacher E; Gülly C; Quehenberger F; Stephan-Falkenau S; Kollmeier J; Roth A; Mairinger T; Popper H
    J Thorac Oncol; 2013 May; 8(5):644-53. PubMed ID: 23449276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pemetrexed: a multitargeted antifolate agent with promising activity in solid tumors.
    Adjei AA
    Ann Oncol; 2000 Oct; 11(10):1335-41. PubMed ID: 11106124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pemetrexed (Alimta): a novel multitargeted antifolate agent.
    Adjei AA
    Expert Rev Anticancer Ther; 2003 Apr; 3(2):145-56. PubMed ID: 12722874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Experience With Pemetrexed in Breast Cancer.
    Martin M
    Semin Oncol; 2006 Feb; 33(Suppl 2):S15-8. PubMed ID: 16472713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pemetrexed and its emerging role in the treatment of thoracic malignancies.
    Scagliotti GV; Novello S
    Expert Opin Investig Drugs; 2003 May; 12(5):853-63. PubMed ID: 12720495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDA drug approval summaries: pemetrexed (Alimta).
    Hazarika M; White RM; Johnson JR; Pazdur R
    Oncologist; 2004; 9(5):482-8. PubMed ID: 15477632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pemetrexed disodium: a novel antifolate clinically active against multiple solid tumors.
    Hanauske AR; Chen V; Paoletti P; Niyikiza C
    Oncologist; 2001; 6(4):363-73. PubMed ID: 11524555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pemetrexed disodium (Eli Lilly).
    Norman P
    Curr Opin Investig Drugs; 2001 Nov; 2(11):1611-22. PubMed ID: 11763166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.